Awardee OrganizationWHITEHEAD INSTITUTE FOR BIOMEDICAL RES
Description
Abstract Text
This proposal focuses on the genetic control of morphogenesis in the
fungus Saccharomyces cerevisiae. The most striking change in shape--the
conversion of a round yeast cell to a long narrow filamentous form has
important implications for human disease. The long thin cells continue
to divide and, remaining attached, form a chain of connected cells or
pseudohypha that can penetrate the surrounding medium. This dimorphic
shift from yeast to filament, common to many fungi pathogenic for humans
(C.albicans, D.neoformans, and H.capsulatum) can now be unraveled by
applying the sophisticated genetic techniques available in Saccharomyces
but lacking in its pathogens. The genes required for pseudohyphal
formation PHD, will be cloned, sequenced and used to create mutations
that block the conversion of the yeast to the filamentous form. The
pathway for pseudohyphal growth will be reconstructed using both the
naturally occurring mutations found in lab stocks (phd5,6,7 in S288C) in
combination with cloned genes that cause pseudohyphal formation when over
expressed. The structure of the pseudohypha in wild type and the phd
mutants will be examined both by light and electron microscopy. The PHD4
gene, which caused adherence to plastic, will be analyzed by molecular
and cell biological techniques and for adherence to endothelial cells,
since adherence is thought to play an important role in deep tissue
invasion by fungi. The second morphogenetic process to be analyzed is
cell fusion during mating. High resolution time lapse microscopy yeast
conjugation will be used to reconstruct the sequence of events in the
fusion process. Key to the unraveling of this pathway will be the
analysis of cell fusion mutants fus 1,2,4,5,6,and 7 and a gene required
for nuclear fusion, BIK1. BIK1 contains distinct functional domains, the
aminoterminus for microtubule association and the carboxyterminus for
nuclear fusion. The dual functions of BIK1p will be dissected by using
biochemical methods, cytological localization of BIK1, the binding of
BIK1p to microtubules and the characterization of genes that are
synthetic lethals with deltabik1 (slbl, 2 and 3). Our work focuses on
the transduction of two external signals key to the activation of the
fusion pathway, mating pheromone and Ca +2. Mutations in FUS3 (encoding
a protein kinase required both for signal transduction and G1 arrest)
that cause constitutive activation of the signal transduction pathway in
the absence of pheromone will be used to determine the role of
phosphorylation of FUS3p in signal transduction. Experiments are
designed to determine whether these mutants are hyperphosphorylated and,
is so, how FUS3p becomes phosphorylated and dephosphorylated. Genes
which mediate the pheromone stimulated Ca+2 requirement, PCR, together
with the genes encoding the plasma membrane (PMC1) and vacuolar calcium
pumps (PMR1) will be used to reconstruct the role of calcium in the
important membrane reorganizations that take place during conjugation.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Candida albicansSaccharomyces cerevisiaeactinsbiological signal transductioncell fusioncytogeneticscytoskeletondevelopmental geneticsfungal geneticsgene expressiongene mutationgene targetinggenetic regulatory elementhistogenesislaboratory mousemicroorganism conjugationmicroorganism sexual dimorphismmitogen activated protein kinasenucleic acid sequencepathologic processphosphorylationpolymerase chain reactionrestriction endonucleasestranscription factoryeast two hybrid system
No Sub Projects information available for 5R01GM040266-16
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01GM040266-16
Patents
No Patents information available for 5R01GM040266-16
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01GM040266-16
Clinical Studies
No Clinical Studies information available for 5R01GM040266-16
News and More
Related News Releases
No news release information available for 5R01GM040266-16
History
No Historical information available for 5R01GM040266-16
Similar Projects
No Similar Projects information available for 5R01GM040266-16